Institut Solaris
Despite their high prevalence (0.3 to 0.6% of the general population) and increasing incidence, there have been no major therapeutic advances in the management of schizophrenic spectrum disorders over the last sixty years.
The prognosis for these disorders remains extremely poor, despite the personal and family tragedies and societal burden they entail.
Their etiology remains as controversial as ever, and recent efforts to dismember an apparently heterogeneous clinical entity into homogeneous subgroups for targeted therapy remain failures.
Accepting such a situation is intolerable!
Research is at a standstill, perpetually reviving subjects already recognized as obsolete, and perpetuating a dichotomy between mindless psychiatry and bodiless psychology in an unwarranted compartmentalization of thought.
The aim of our institute is to encourage the development and diffusion of totally new research projects, likely to initiate qualitative ruptures in the management and prognosis of conditions as dramatic as they are frequent.
All contributions are welcome.
Dr François Besson
Contact